EUVIMEDEUVIMED entdecken
Querschnittstudie

Current Use of Neoadjuvant Hedgehog Inhibitors Among Mohs Surgeons: Results of a Cross-Sectional Survey

Lauren Gresham, Grant Randall, Jesalyn A Tate

Journal of Drugs in Dermatology · 2025

DOI: 10.36849/jdd.9105 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Journal of Drugs in Dermatology, 2025. Verfasst von Lauren Gresham und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Mohs Surgery, Basal Cell Carcinoma, Hedgehog Proteins, Neoadjuvant Therapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mohs SurgeryBasal Cell CarcinomaHedgehog ProteinsNeoadjuvant TherapySkin NeoplasmsSurgeonsPractice Patterns, Physicians'Antineoplastic AgentsHumansCross-Sectional StudiesSurveys and Questionnaires

Substanzen

Hedgehog ProteinsAntineoplastic Agents

Zitieren

APA

Gresham, L., Randall, G., & Tate, J. A. (2025). Current Use of Neoadjuvant Hedgehog Inhibitors Among Mohs Surgeons: Results of a Cross-Sectional Survey. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.9105

Vancouver

Gresham L, Randall G, Tate JA. Current Use of Neoadjuvant Hedgehog Inhibitors Among Mohs Surgeons: Results of a Cross-Sectional Survey. Journal of Drugs in Dermatology. 2025. doi:10.36849/jdd.9105

BibTeX
@article{Gresham2025,
  author = {Gresham, Lauren and Randall, Grant and Tate, Jesalyn A},
  title = {Current Use of Neoadjuvant Hedgehog Inhibitors Among Mohs Surgeons: Results of a Cross-Sectional Survey},
  journal = {Journal of Drugs in Dermatology},
  year = {2025},
  doi = {10.36849/jdd.9105}
}
Kostenlos starten →